Reactive oxygen species (ROS) have emerged as a promising
treatment
option for antibacterial and biofilm eradication. However, their therapeutic
efficacy is significantly hampered by the unique microenvironments
of diabetic wounds. In this study, we designed and synthesized porphyrin-based
Fe covalent organic frameworks (Fe-COF) through a Schiff base condensation
reaction. Subsequently, Fe-COF were encapsulated with hyaluronic acid
(HA) through electrostatic adsorption, resulting in a novel formulation
named HA-Fe-COF for diabetic wound healing. HA-Fe-COF were engineered
to respond to hyaluronidase in the infected wound, leading to the
controlled release of Fe-COF. Those released Fe-COF served a dual
role as photosensitizers, generating singlet oxygen and localized
heating when exposed to dual light sources. Additionally, they acted
as peroxidase-like nanozymes, facilitating the production of ROS through
enzymatic reactions. This innovative approach enabled a synergistic
therapeutic effect combining photodynamic, photothermal, and chemodynamic
modalities. Furthermore, the sustained release of HA from HA-Fe-COF
promoted angiogenesis, collagen deposition, and re-epithelialization
during the diabetic wound healing process. This “all-in-one”
strategy offers a novel approach for the development of antimicrobial
and biofilm eradication strategies that minimize damage to healthy
tissues in vivo.